NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD - Announcements

2.78%

17.5¢

Market Cap $59.86M

Healthcare Biotechnology

NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is... NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is engaged in developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company's product portfolio includes EmtinB, a therapeutic peptide initially targeting glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn and EmtinBn). EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body's innate immune response to cell injury. Its StemSmart is a global patented technology engaged in manufacturing cell products. The use of its proprietary StemSmart technology in a special access program for fistulising Crohn’s disease.More

ASX:PAR

This stock could have something close to a cure for osteoarthritis. Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.

Announcements

Filter Results

All Price Sensitive Only

NSB	Date of AGM & Closing Date for Director Nominations		16/09/25	117.11KB	Share
NSB	Notification regarding unquoted securities - NSB		16/09/25	24.86KB	Share
NSB	Appendix 4G & Corporate Governance Statement		28/08/25	469.54KB	Share
NSB	2025 Annual Report & Appendix 4E	PRICE SENSITIVE	28/08/25	1.96MB	Share
NSB	Previous StemSmart Studies Support Renal Transplantation	PRICE SENSITIVE	27/08/25	308.92KB	Share
NSB	Presentation - TechKnow Invest Roadshow Conference		19/08/25	669.31KB	Share
NSB	NeuroScientific Partners with Leading Biologic Manufacturer		31/07/25	273.24KB	Share
NSB	Change in substantial holding		30/07/25	148.5KB	Share
NSB	Experienced Cell Therapy Executive Appointed CEO	PRICE SENSITIVE	28/07/25	470.44KB	Share
NSB	Dr Catherine Cole Appointed as Chief Medical Officer		25/07/25	369.38KB	Share
NSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	23/07/25	1.35MB	Share
NSB	Becoming a substantial holder		10/07/25	87.23KB	Share
NSB	Change in substantial holding		04/07/25	81.89KB	Share
NSB	Change of Director's Interest Notice (AU)		01/07/25	407.87KB	Share
NSB	Breakthrough Stem Cell Tech Acquired-StemSmart Presentation		30/06/25	795.68KB	Share
NSB	StemSmart Acquisition Complete	PRICE SENSITIVE	27/06/25	529.19KB	Share
NSB	Initial Director's Interest Notice x2		27/06/25	913.47KB	Share
NSB	Change of Director's Interest Notice x2		27/06/25	812.11KB	Share
NSB	Final Director's Interest Notice x2		27/06/25	911.52KB	Share
NSB	Section 708A Notice		27/06/25	614.59KB	Share
NSB	Notification regarding unquoted securities - NSB		27/06/25	17.33KB	Share
NSB	Notification regarding unquoted securities - NSB		27/06/25	17.36KB	Share
NSB	Application for quotation of securities - NSB		27/06/25	15.71KB	Share
NSB	Application for quotation of securities - NSB		27/06/25	15.75KB	Share
NSB	Application for quotation of securities - NSB		27/06/25	15.61KB	Share
NSB	Results of General Meeting		23/06/25	471.08KB	Share
NSB	Previous StemSmart Studies Demonstrate Clinical Response	PRICE SENSITIVE	19/06/25	738.35KB	Share
NSB	Notification of cessation of securities - NSB		18/06/25	12.71KB	Share
NSB	Proposed issue of securities - NSB		26/05/25	16.54KB	Share
NSB	Letter to Shareholders & Proxy Form		23/05/25	498.84KB	Share
NSB	Notice of General Meeting & Proxy Form		23/05/25	548.41KB	Share
NSB	Special Access Program Set to Commence		23/05/25	515.57KB	Share
NSB	Change of Director's Interest Notice		14/05/25	1.11MB	Share
NSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	24/04/25	1.3MB	Share
NSB	Proposed issue of securities - NSB		16/04/25	19.35KB	Share
NSB	Proposed issue of securities - NSB		16/04/25	18.52KB	Share
NSB	NeuroScientific to Acquire Leading Stem Cell Technology	PRICE SENSITIVE	16/04/25	700.95KB	Share
NSB	Trading Halt	PRICE SENSITIVE	14/04/25	920.7KB	Share
NSB	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/25	3.53MB	Share
NSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/25	1.33MB	Share
NSB	Change of Registered Office Address		24/01/25	509.03KB	Share
NSB	Notification of cessation of securities - NSB		22/01/25	12.76KB	Share
NSB	Results of Annual General Meeting		06/11/24	463.79KB	Share
NSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/24	1.32MB	Share
NSB	Letter to Shareholders and Proxy Form		02/10/24	496.33KB	Share
NSB	Notice of Annual General Meeting		02/10/24	430.93KB	Share
NSB	Appendix 4G & Corporate Governance Statement		29/08/24	762.4KB	Share
NSB	2024 Annual Report & Appendix 4E	PRICE SENSITIVE	29/08/24	6.37MB	Share
NSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	19/07/24	1.23MB	Share
NSB	Notice of Release of Escrowed Securities		10/07/24	408.07KB	Share
NSB	NSB Completes PRE-IND Meeting with US FDA on EmtinB		11/06/24	412.17KB	Share
NSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/24	1.31MB	Share
NSB	Notification of cessation of securities - NSB		08/04/24	12.77KB	Share
NSB	Appointment of Executive Director & FDA Pre-Ind Meeting	PRICE SENSITIVE	02/04/24	416.34KB	Share
NSB	NSB Receives A$2.2M Research & Development Tax Refund	PRICE SENSITIVE	20/03/24	410.52KB	Share
NSB	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/24	1.01MB	Share
NSB	Company Secretary Appointment/Resignation		06/02/24	115.12KB	Share
NSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	311.96KB	Share
NSB	Notification of cessation of securities - NSB		15/01/24	21.59KB	Share
NSB	Expiry of Options		27/12/23	234.24KB	Share
NSB	Final Director's Interest Notice - Rennie		07/12/23	3.33KB	Share
NSB	Final Director's Interest Notice - Quantrill		05/12/23	3.43KB	Share
NSB	Initial Director's Interest Notice - Keating		05/12/23	228.43KB	Share
NSB	Changes to NSB Board		05/12/23	184.23KB	Share
NSB	Resignation of CEO	PRICE SENSITIVE	01/12/23	178.63KB	Share
NSB	Results of Meeting		30/11/23	285.36KB	Share
NSB	Chair's address to shareholders & AGM presentation		30/11/23	1.63MB	Share
NSB	Notice of Annual General Meeting - Withdrawal of Resolutions		27/11/23	157KB	Share
NSB	Initial Director's Interest Notice - Barlow		21/11/23	226.14KB	Share
NSB	Initial Director's Interest Notice - Ntoumenopoulos		21/11/23	227.89KB	Share
NSB	Notification of cessation of securities - NSB		21/11/23	21.66KB	Share
NSB	Addendum to Notice of Meeting		16/11/23	630.92KB	Share
NSB	Further information on changes to Board		14/11/23	158.29KB	Share
NSB	Changes to Board		13/11/23	169.11KB	Share
NSB	Investor Update Presentation		31/10/23	2.38MB	Share
NSB	Investor Update Webinar		30/10/23	150.57KB	Share
NSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/10/23	357.42KB	Share
NSB	Notification regarding unquoted securities - NSB		24/10/23	28.78KB	Share
NSB	Proposed issue of securities - NSB		24/10/23	27.86KB	Share
NSB	Notice of Annual General Meeting/Proxy Form		24/10/23	412.54KB	Share
NSB	Proposed issue of securities - NSB		23/10/23	26.88KB	Share
NSB	Appointment of Director - Dr Linda Friedland		18/10/23	219.75KB	Share
NSB	Date of AGM & Closing Date for Director Nominations		28/09/23	165.12KB	Share
NSB	Appointment of CEO	PRICE SENSITIVE	31/08/23	154.04KB	Share
NSB	Appendix 4G		30/08/23	258.67KB	Share
NSB	Corporate Governance Statement		30/08/23	228.23KB	Share
NSB	2023 Annual Report and Appendix 4E	PRICE SENSITIVE	25/08/23	1.6MB	Share
NSB	Expiry of Performance Shares		01/08/23	153.59KB	Share
NSB	Notification of cessation of securities - NSB		01/08/23	21.82KB	Share
NSB	Issuance of Shares		01/08/23	159.19KB	Share
NSB	Application for quotation of securities - NSB		01/08/23	24.71KB	Share
NSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/23	339.28KB	Share
NSB	Proposed issue of securities - NSB		27/07/23	24.67KB	Share
NSB	Change of Director's Interest Notice - Quantrill		06/07/23	4.45KB	Share
NSB	Change of Director's Interest Notice - Rennie		07/06/23	8.12KB	Share
NSB	Change of Director's Interest Notice - Uvarov		25/05/23	9.25KB	Share
NSB	Change of Director's Interest Notice - Rennie		25/05/23	8.11KB	Share
NSB	Change of Director's Interest Notice - Uvarov		19/05/23	9.26KB	Share
NSB	Change of Director's Interest Notice - Rennie		18/05/23	8.29KB	Share
NSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/23	309.87KB	Share

NSB Date of AGM & Closing Date for Director Nominations
16/09/25		117.11KB	Share
NSB Notification regarding unquoted securities - NSB
16/09/25		24.86KB	Share
NSB Appendix 4G & Corporate Governance Statement
28/08/25		469.54KB	Share
NSB 2025 Annual Report & Appendix 4E
28/08/25	PRICE SENSITIVE	1.96MB	Share
NSB Previous StemSmart Studies Support Renal Transplantation
27/08/25	PRICE SENSITIVE	308.92KB	Share
NSB Presentation - TechKnow Invest Roadshow Conference
19/08/25		669.31KB	Share
NSB NeuroScientific Partners with Leading Biologic Manufacturer
31/07/25		273.24KB	Share
NSB Change in substantial holding
30/07/25		148.5KB	Share
NSB Experienced Cell Therapy Executive Appointed CEO
28/07/25	PRICE SENSITIVE	470.44KB	Share
NSB Dr Catherine Cole Appointed as Chief Medical Officer
25/07/25		369.38KB	Share
NSB Quarterly Activities/Appendix 4C Cash Flow Report
23/07/25	PRICE SENSITIVE	1.35MB	Share
NSB Becoming a substantial holder
10/07/25		87.23KB	Share
NSB Change in substantial holding
04/07/25		81.89KB	Share
NSB Change of Director's Interest Notice (AU)
01/07/25		407.87KB	Share
NSB Breakthrough Stem Cell Tech Acquired-StemSmart Presentation
30/06/25		795.68KB	Share
NSB StemSmart Acquisition Complete
27/06/25	PRICE SENSITIVE	529.19KB	Share
NSB Initial Director's Interest Notice x2
27/06/25		913.47KB	Share
NSB Change of Director's Interest Notice x2
27/06/25		812.11KB	Share
NSB Final Director's Interest Notice x2
27/06/25		911.52KB	Share
NSB Section 708A Notice
27/06/25		614.59KB	Share
NSB Notification regarding unquoted securities - NSB
27/06/25		17.33KB	Share
NSB Notification regarding unquoted securities - NSB
27/06/25		17.36KB	Share
NSB Application for quotation of securities - NSB
27/06/25		15.71KB	Share
NSB Application for quotation of securities - NSB
27/06/25		15.75KB	Share
NSB Application for quotation of securities - NSB
27/06/25		15.61KB	Share
NSB Results of General Meeting
23/06/25		471.08KB	Share
NSB Previous StemSmart Studies Demonstrate Clinical Response
19/06/25	PRICE SENSITIVE	738.35KB	Share
NSB Notification of cessation of securities - NSB
18/06/25		12.71KB	Share
NSB Proposed issue of securities - NSB
26/05/25		16.54KB	Share
NSB Letter to Shareholders & Proxy Form
23/05/25		498.84KB	Share
NSB Notice of General Meeting & Proxy Form
23/05/25		548.41KB	Share
NSB Special Access Program Set to Commence
23/05/25		515.57KB	Share
NSB Change of Director's Interest Notice
14/05/25		1.11MB	Share
NSB Quarterly Activities/Appendix 4C Cash Flow Report
24/04/25	PRICE SENSITIVE	1.3MB	Share
NSB Proposed issue of securities - NSB
16/04/25		19.35KB	Share
NSB Proposed issue of securities - NSB
16/04/25		18.52KB	Share
NSB NeuroScientific to Acquire Leading Stem Cell Technology
16/04/25	PRICE SENSITIVE	700.95KB	Share
NSB Trading Halt
14/04/25	PRICE SENSITIVE	920.7KB	Share
NSB Half Yearly Report and Accounts
26/02/25	PRICE SENSITIVE	3.53MB	Share
NSB Quarterly Activities/Appendix 4C Cash Flow Report
30/01/25	PRICE SENSITIVE	1.33MB	Share
NSB Change of Registered Office Address
24/01/25		509.03KB	Share
NSB Notification of cessation of securities - NSB
22/01/25		12.76KB	Share
NSB Results of Annual General Meeting
06/11/24		463.79KB	Share
NSB Quarterly Activities/Appendix 4C Cash Flow Report
29/10/24	PRICE SENSITIVE	1.32MB	Share
NSB Letter to Shareholders and Proxy Form
02/10/24		496.33KB	Share
NSB Notice of Annual General Meeting
02/10/24		430.93KB	Share
NSB Appendix 4G & Corporate Governance Statement
29/08/24		762.4KB	Share
NSB 2024 Annual Report & Appendix 4E
29/08/24	PRICE SENSITIVE	6.37MB	Share
NSB Quarterly Activities/Appendix 4C Cash Flow Report
19/07/24	PRICE SENSITIVE	1.23MB	Share
NSB Notice of Release of Escrowed Securities
10/07/24		408.07KB	Share
NSB NSB Completes PRE-IND Meeting with US FDA on EmtinB
11/06/24		412.17KB	Share
NSB Quarterly Activities/Appendix 4C Cash Flow Report
29/04/24	PRICE SENSITIVE	1.31MB	Share
NSB Notification of cessation of securities - NSB
08/04/24		12.77KB	Share
NSB Appointment of Executive Director & FDA Pre-Ind Meeting
02/04/24	PRICE SENSITIVE	416.34KB	Share
NSB NSB Receives A$2.2M Research & Development Tax Refund
20/03/24	PRICE SENSITIVE	410.52KB	Share
NSB Half Yearly Report and Accounts
27/02/24	PRICE SENSITIVE	1.01MB	Share
NSB Company Secretary Appointment/Resignation
06/02/24		115.12KB	Share
NSB Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	311.96KB	Share
NSB Notification of cessation of securities - NSB
15/01/24		21.59KB	Share
NSB Expiry of Options
27/12/23		234.24KB	Share
NSB Final Director's Interest Notice - Rennie
07/12/23		3.33KB	Share
NSB Final Director's Interest Notice - Quantrill
05/12/23		3.43KB	Share
NSB Initial Director's Interest Notice - Keating
05/12/23		228.43KB	Share
NSB Changes to NSB Board
05/12/23		184.23KB	Share
NSB Resignation of CEO
01/12/23	PRICE SENSITIVE	178.63KB	Share
NSB Results of Meeting
30/11/23		285.36KB	Share
NSB Chair's address to shareholders & AGM presentation
30/11/23		1.63MB	Share
NSB Notice of Annual General Meeting - Withdrawal of Resolutions
27/11/23		157KB	Share
NSB Initial Director's Interest Notice - Barlow
21/11/23		226.14KB	Share
NSB Initial Director's Interest Notice - Ntoumenopoulos
21/11/23		227.89KB	Share
NSB Notification of cessation of securities - NSB
21/11/23		21.66KB	Share
NSB Addendum to Notice of Meeting
16/11/23		630.92KB	Share
NSB Further information on changes to Board
14/11/23		158.29KB	Share
NSB Changes to Board
13/11/23		169.11KB	Share
NSB Investor Update Presentation
31/10/23		2.38MB	Share
NSB Investor Update Webinar
30/10/23		150.57KB	Share
NSB Quarterly Activities/Appendix 4C Cash Flow Report
30/10/23	PRICE SENSITIVE	357.42KB	Share
NSB Notification regarding unquoted securities - NSB
24/10/23		28.78KB	Share
NSB Proposed issue of securities - NSB
24/10/23		27.86KB	Share
NSB Notice of Annual General Meeting/Proxy Form
24/10/23		412.54KB	Share
NSB Proposed issue of securities - NSB
23/10/23		26.88KB	Share
NSB Appointment of Director - Dr Linda Friedland
18/10/23		219.75KB	Share
NSB Date of AGM & Closing Date for Director Nominations
28/09/23		165.12KB	Share
NSB Appointment of CEO
31/08/23	PRICE SENSITIVE	154.04KB	Share
NSB Appendix 4G
30/08/23		258.67KB	Share
NSB Corporate Governance Statement
30/08/23		228.23KB	Share
NSB 2023 Annual Report and Appendix 4E
25/08/23	PRICE SENSITIVE	1.6MB	Share
NSB Expiry of Performance Shares
01/08/23		153.59KB	Share
NSB Notification of cessation of securities - NSB
01/08/23		21.82KB	Share
NSB Issuance of Shares
01/08/23		159.19KB	Share
NSB Application for quotation of securities - NSB
01/08/23		24.71KB	Share
NSB Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23	PRICE SENSITIVE	339.28KB	Share
NSB Proposed issue of securities - NSB
27/07/23		24.67KB	Share
NSB Change of Director's Interest Notice - Quantrill
06/07/23		4.45KB	Share
NSB Change of Director's Interest Notice - Rennie
07/06/23		8.12KB	Share
NSB Change of Director's Interest Notice - Uvarov
25/05/23		9.25KB	Share
NSB Change of Director's Interest Notice - Rennie
25/05/23		8.11KB	Share
NSB Change of Director's Interest Notice - Uvarov
19/05/23		9.26KB	Share
NSB Change of Director's Interest Notice - Rennie
18/05/23		8.29KB	Share
NSB Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23	PRICE SENSITIVE	309.87KB	Share

REFRESH

1 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 17.5¢		Change -0.005(2.78%)		Mkt cap ! $59.86M

Open	High	Low	Value	Volume
17.5¢	18.0¢	17.5¢	$11.74K	67.11K

Buyers (Bids)

No.	Vol.	Price($)
2	50300	17.0¢

Sellers (Offers)

Price($)	Vol.	No.
18.0¢	132200	5

View Market Depth

No.	Vol.	Price($)
2	50300	0.170
4	69316	0.165
6	213232	0.160
2	42209	0.155
4	30574	0.150

Price($)	Vol.	No.
0.180	132200	5
0.185	92378	5
0.190	351356	3
0.195	38000	3
0.200	374501	5

Last trade - 10.08am 18/09/2025 (20 minute delay)


Last 17.5¢		Change -0.005 ( 2.94 %)
Open	High	Low	Volume
17.5¢	17.5¢	17.5¢	9744
Last updated 10.03am 18/09/2025 ?

NSB (ASX) Chart

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories